Company Profiles

driven by the PitchBook Platform

Milestone Pharmaceuticals

Description

Developer of cardiovascular drugs. The company develops small molecule therapeutics for the treatment of inflammatory and cardiovascular diseases. Its product includes a short-acting calcium channel antagonist for the treatment of transient cardiovascular conditions, such as atrial arrhythmias.

2005

Founded

PRIVATE

Status

Series B

Latest Deal Type

$17M

Latest Deal Amount

$34M

Total Amount Raised

7

Investors

Description

Developer of cardiovascular drugs. The company develops small molecule therapeutics for the treatment of inflammatory and cardiovascular diseases. Its product includes a short-acting calcium channel antagonist for the treatment of transient cardiovascular conditions, such as atrial arrhythmias.

Website:

www.milestonepharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

1111 Drive, Frederik-Philips Boulevard Suite 420 Saint-Laurent, Quebec H4M 2X6Canada +1 (514) 336-0444
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Milestone Pharmaceuticals's full profile, request a free trial.

Milestone Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Milestone Pharmaceuticals Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BDC Healthcare Venture FundVenture CapitalMinority000 0000000 0000
Domain AssociatesVenture CapitalMinority000 0000000 0000
Fonds Bio-InnovationOtherMinority000 0000000 0000
Fonds de solidarité FTQVenture CapitalMinority000 0000000 0000
GO Capital (France)Venture CapitalMinority000 0000000 0000
BDC Healthcare Venture Fund Venture Capital
Domain Associates Venture Capital
Fonds Bio-Innovation Other
Fonds de solidarité FTQ Venture Capital
GO Capital (France) Venture Capital

Milestone Pharmaceuticals Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Philippe Douville Ph.DChief Executive Officer & Board Member
Jeff LeightonFounder & Chief Scientific Officer & Chief Scientific Advisor
Yves RosconiIndependent Director
Martin Maguire Ph.DVice President, Chemistry & Manufacturing
Benjamin Cowen Ph.DVice President, Corporate Development
Philippe Douville Ph.D Chief Executive Officer & Board Member
Jeff Leighton Founder & Chief Scientific Officer & Chief Scientific Advisor
Yves Rosconi Independent Director
Martin Maguire Ph.D Vice President, Chemistry & Manufacturing
Benjamin Cowen Ph.D Vice President, Corporate Development

Milestone Pharmaceuticals Board Members (6)

NameRepresentingRoleSinceContact
Info
Debra LiebertDomain AssociatesManaging Director000 0000
Ela BorensteinBDC Healthcare Venture FundBoard Member000 0000
Paul TruexSelfChairman000 0000
Philippe Douville Ph.DMilestone PharmaceuticalsChief Executive Officer & Board Member000 0000
Rodney Altman MDSelfBoard Member000 0000
Debra Liebert Managing Director Domain Associates
Ela Borenstein Board Member BDC Healthcare Venture Fund
Paul Truex Chairman Self
Philippe Douville Ph.D Chief Executive Officer & Board Member Milestone Pharmaceuticals
Rodney Altman MD Board Member Self
Request full access to PitchBook